CLINICAL-EVALUATION OF GLIMEPIRIDE (HOE490) IN NIDDM, INCLUDING A DOUBLE-BLIND COMPARATIVE-STUDY VERSUS GLICLAZIDE

被引：15

作者：

TSUMURA, K

机构：

[1] Hoechst Japan Limited, Pharma Clinical Research Department, Minato-ku, Tokyo

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 1995年 / 28卷

关键词：

GLIMEPIRIDE; GLICLAZIDE; SULFONYLUREA; NIDDM; DOUBLE BLIND STUDY;

D O I：

10.1016/0168-8227(95)01104-L

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In order to investigate the clinical usefulness of glimepiride in NIDDM, some clinical trials were conducted. In a double-blind comparative study versus gliclazide, glimepiride was as efficacious as gliclazide. However, a subgroup analysis suggested glimepiride may have been more effective in severe patients treated by large doses of glibenclamide.

引用

页码：S147 / S149

页数：3